{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:51:38Z","timestamp":1794084698257,"version":"4.8.0"},"reference-count":238,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41569-021-00552-1","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T07:02:40Z","timestamp":1620284560000},"page":"666-682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1026,"title":["Interplay between inflammation and thrombosis in cardiovascular pathology"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5369-8399","authenticated-orcid":false,"given":"Konstantin","family":"Stark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-3986","authenticated-orcid":false,"given":"Steffen","family":"Massberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"552_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34\u201345 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"552_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120\u2013128 (2020).","journal-title":"N. Engl. J. Med."},{"key":"552_CR3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","volume":"142","author":"L Nicolai","year":"2020","unstructured":"Nicolai, L. et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation 142, 1176\u20131189 (2020).","journal-title":"Circulation"},{"key":"552_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"D Wichmann","year":"2020","unstructured":"Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173, 268\u2013277 (2020).","journal-title":"Ann. Intern. Med."},{"key":"552_CR5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010459","volume":"382","author":"C Creel-Bulos","year":"2020","unstructured":"Creel-Bulos, C. et al. Acute cor pulmonale in critically ill patients with Covid-19. N. Engl. J. Med. 382, e70 (2020).","journal-title":"N. Engl. J. Med."},{"key":"552_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui, S., Chen, S., Li, X., Liu, S. & Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 18, 1421\u20131424 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 191, 148\u2013150 (2020).","journal-title":"Thromb. Res."},{"key":"552_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 191, 145\u2013147 (2020).","journal-title":"Thromb. Res."},{"key":"552_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","volume":"142","author":"J Poissy","year":"2020","unstructured":"Poissy, J. et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 142, 184\u2013186 (2020).","journal-title":"Circulation"},{"key":"552_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley, T. J. et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N. Engl. J. Med. 382, e60 (2020).","journal-title":"N. Engl. J. Med."},{"key":"552_CR11","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMc2009020","volume":"382","author":"S Bangalore","year":"2020","unstructured":"Bangalore, S. et al. ST-segment elevation in patients with Covid-19 \u2013 a case series. N. Engl. J. Med. 382, 2478\u20132480 (2020).","journal-title":"N. Engl. J. Med."},{"key":"552_CR12","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.120.047525","volume":"141","author":"GG Stefanini","year":"2020","unstructured":"Stefanini, G. G. et al. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation 141, 2113\u20132116 (2020).","journal-title":"Circulation"},{"key":"552_CR13","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.2515","volume":"17","author":"SP Jackson","year":"2011","unstructured":"Jackson, S. P. Arterial thrombosis\u2013insidious, unpredictable and deadly. Nat. Med. 17, 1423\u20131436 (2011).","journal-title":"Nat. Med."},{"key":"552_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature06797","volume":"451","author":"N Mackman","year":"2008","unstructured":"Mackman, N. Triggers, targets and treatments for thrombosis. Nature 451, 914\u2013918 (2008).","journal-title":"Nature"},{"key":"552_CR15","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI60229","volume":"122","author":"N Mackman","year":"2012","unstructured":"Mackman, N. New insights into the mechanisms of venous thrombosis. J. Clin. Invest. 122, 2331\u20132336 (2012).","journal-title":"J. Clin. Invest."},{"key":"552_CR16","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1182\/blood-2013-05-504449","volume":"122","author":"ED Hottz","year":"2013","unstructured":"Hottz, E. D. et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 122, 3405\u20133414 (2013).","journal-title":"Blood"},{"key":"552_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","volume":"11","author":"JW Semple","year":"2011","unstructured":"Semple, J. W., Italiano, J. E. Jr. & Freedman, J. Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264\u2013274 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"552_CR18","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.cell.2017.11.001","volume":"171","author":"F Gaertner","year":"2017","unstructured":"Gaertner, F. et al. Migrating platelets are mechano-scavengers that collect and bundle bacteria. Cell 171, 1368\u20131382 (2017).","journal-title":"Cell"},{"key":"552_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19515-0","volume":"11","author":"L Nicolai","year":"2020","unstructured":"Nicolai, L. et al. Vascular surveillance by haptotactic blood platelets in inflammation and infection. Nat. Commun. 11, 5778 (2020).","journal-title":"Nat. Commun."},{"key":"552_CR20","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"552_CR21","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl Acad. Sci. USA 107, 15880\u201315885 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"552_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Bruhl","year":"2012","unstructured":"von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819\u2013835 (2012).","journal-title":"J. Exp. Med."},{"key":"552_CR23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.2053","volume":"15","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15, 1318\u20131321 (2009).","journal-title":"Nat. Med."},{"key":"552_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.24437","volume":"6","author":"EF Kenny","year":"2017","unstructured":"Kenny, E. F. et al. Diverse stimuli engage different neutrophil extracellular trap pathways. eLife 6, e24437 (2017).","journal-title":"eLife"},{"key":"552_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nchembio.1735","volume":"11","author":"HD Lewis","year":"2015","unstructured":"Lewis, H. D. et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat. Chem. Biol. 11, 189\u2013191 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"552_CR26","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1073\/pnas.1301059110","volume":"110","author":"K Martinod","year":"2013","unstructured":"Martinod, K. et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl Acad. Sci. USA 110, 8674\u20138679 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"552_CR27","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"key":"552_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.devcel.2018.01.019","volume":"44","author":"G Sollberger","year":"2018","unstructured":"Sollberger, G., Tilley, D. O. & Zychlinsky, A. Neutrophil extracellular traps: the biology of chromatin externalization. Dev. Cell 44, 542\u2013553 (2018).","journal-title":"Dev. Cell"},{"key":"552_CR29","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2016-01-688887","volume":"127","author":"C Silvestre-Roig","year":"2016","unstructured":"Silvestre-Roig, C., Hidalgo, A. & Soehnlein, O. Neutrophil heterogeneity: implications for homeostasis and pathogenesis. Blood 127, 2173\u20132181 (2016).","journal-title":"Blood"},{"key":"552_CR30","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1182\/blood-2016-05-718999","volume":"128","author":"B Uhl","year":"2016","unstructured":"Uhl, B. et al. Aged neutrophils contribute to the first line of defense in the acute inflammatory response. Blood 128, 2327\u20132337 (2016).","journal-title":"Blood"},{"key":"552_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature15367","volume":"525","author":"D Zhang","year":"2015","unstructured":"Zhang, D. et al. Neutrophil ageing is regulated by the microbiome. Nature 525, 528\u2013532 (2015).","journal-title":"Nature"},{"key":"552_CR32","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.aam8897","volume":"358","author":"M Jimenez-Alcazar","year":"2017","unstructured":"Jimenez-Alcazar, M. et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science 358, 1202\u20131206 (2017).","journal-title":"Science"},{"key":"552_CR33","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim, A. et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl Acad. Sci. USA 107, 9813\u20139818 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"552_CR34","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.1256478","volume":"346","author":"V Sreeramkumar","year":"2014","unstructured":"Sreeramkumar, V. et al. Neutrophils scan for activated platelets to initiate inflammation. Science 346, 1234\u20131238 (2014).","journal-title":"Science"},{"key":"552_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"SR Clark","year":"2007","unstructured":"Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463\u2013469 (2007).","journal-title":"Nat. Med."},{"key":"552_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13464","volume":"7","author":"J Rossaint","year":"2016","unstructured":"Rossaint, J. et al. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat. Commun. 7, 13464 (2016).","journal-title":"Nat. Commun."},{"key":"552_CR37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1160\/TH13-02-0102","volume":"110","author":"A Verschoor","year":"2013","unstructured":"Verschoor, A. & Langer, H. F. Crosstalk between platelets and the complement system in immune protection and disease. Thromb. Haemost. 110, 910\u2013919 (2013).","journal-title":"Thromb. Haemost."},{"key":"552_CR38","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1182\/blood-2017-10-811943","volume":"130","author":"CQ Schmidt","year":"2017","unstructured":"Schmidt, C. Q. & Verschoor, A. Complement and coagulation: so close, yet so far. Blood 130, 2581\u20132582 (2017).","journal-title":"Blood"},{"key":"552_CR39","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.molimm.2010.05.009","volume":"47","author":"EI Peerschke","year":"2010","unstructured":"Peerschke, E. I., Yin, W. & Ghebrehiwet, B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol. Immunol. 47, 2170\u20132175 (2010).","journal-title":"Mol. Immunol."},{"key":"552_CR40","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1084\/jem.147.6.1713","volume":"147","author":"MJ Polley","year":"1978","unstructured":"Polley, M. J. & Nachman, R. The human complement system in thrombin-mediated platelet function. J. Exp. Med. 147, 1713\u20131726 (1978).","journal-title":"J. Exp. Med."},{"key":"552_CR41","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ni.2140","volume":"12","author":"A Verschoor","year":"2011","unstructured":"Verschoor, A. et al. A platelet-mediated system for shuttling blood-borne bacteria to CD8\u03b1+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat. Immunol. 12, 1194\u20131201 (2011).","journal-title":"Nat. Immunol."},{"key":"552_CR42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nm.2184","volume":"16","author":"S Massberg","year":"2010","unstructured":"Massberg, S. et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16, 887\u2013896 (2010).","journal-title":"Nat. Med."},{"key":"552_CR43","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/nm.2847","volume":"18","author":"BG Yipp","year":"2012","unstructured":"Yipp, B. G. et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18, 1386\u20131393 (2012).","journal-title":"Nat. Med."},{"key":"552_CR44","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.immuni.2019.04.003","volume":"50","author":"C Wu","year":"2019","unstructured":"Wu, C. et al. Inflammasome activation triggers blood clotting and host death through pyroptosis. Immunity 50, 1401\u20131411 (2019).","journal-title":"Immunity"},{"key":"552_CR45","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1021\/bi00362a005","volume":"25","author":"R Bach","year":"1986","unstructured":"Bach, R., Gentry, R. & Nemerson, Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry 25, 4007\u20134020 (1986).","journal-title":"Biochemistry"},{"key":"552_CR46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.immuni.2019.11.005","volume":"51","author":"X Yang","year":"2019","unstructured":"Yang, X. et al. Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure. Immunity 51, 983\u2013996 (2019).","journal-title":"Immunity"},{"key":"552_CR47","first-page":"1110","volume":"118","author":"C Reinhardt","year":"2008","unstructured":"Reinhardt, C. et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J. Clin. Invest. 118, 1110\u20131122 (2008).","journal-title":"J. Clin. Invest."},{"key":"552_CR48","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.immuni.2019.03.003","volume":"50","author":"LC Burzynski","year":"2019","unstructured":"Burzynski, L. C. et al. The coagulation and immune systems are directly linked through the activation of interleukin-1\u03b1 by thrombin. Immunity 50, 1033\u20131042 (2019).","journal-title":"Immunity"},{"key":"552_CR49","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1182\/blood-2017-06-780882","volume":"130","author":"EM Pietras","year":"2017","unstructured":"Pietras, E. M. Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood 130, 1693\u20131698 (2017).","journal-title":"Blood"},{"key":"552_CR50","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.stem.2015.07.007","volume":"17","author":"S Haas","year":"2015","unstructured":"Haas, S. et al. Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell 17, 422\u2013434 (2015).","journal-title":"Cell Stem Cell"},{"key":"552_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fimmu.2016.00366","volume":"7","author":"G Sch\u00f6nrich","year":"2016","unstructured":"Sch\u00f6nrich, G. & Raftery, M. J. Neutrophil extracellular traps go viral. Front. Immunol. 7, 366 (2016).","journal-title":"Front. Immunol."},{"key":"552_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chom.2013.01.005","volume":"13","author":"CN Jenne","year":"2013","unstructured":"Jenne, C. N. et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13, 169\u2013180 (2013).","journal-title":"Cell Host Microbe"},{"key":"552_CR53","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2013-07-515536","volume":"123","author":"E Boilard","year":"2014","unstructured":"Boilard, E. et al. Influenza virus H1N1 activates platelets through Fc\u03b3RIIA signaling and thrombin generation. Blood 123, 2854\u20132863 (2014).","journal-title":"Blood"},{"key":"552_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09607-x","volume":"10","author":"M Koupenova","year":"2019","unstructured":"Koupenova, M. et al. The role of platelets in mediating a response to human influenza infection. Nat. Commun. 10, 1780 (2019).","journal-title":"Nat. Commun."},{"key":"552_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124082","volume":"10","author":"GA Funchal","year":"2015","unstructured":"Funchal, G. A. et al. Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils. PLoS ONE 10, e0124082 (2015).","journal-title":"PLoS ONE"},{"key":"552_CR56","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1189\/jlb.4A1113-604RR","volume":"96","author":"S Tripathi","year":"2014","unstructured":"Tripathi, S., Verma, A., Kim, E. J., White, M. R. & Hartshorn, K. L. LL-37 modulates human neutrophil responses to influenza A virus. J. Leukoc. Biol. 96, 931\u2013938 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"552_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","volume":"179","author":"T Narasaraju","year":"2011","unstructured":"Narasaraju, T. et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 179, 199\u2013210 (2011).","journal-title":"Am. J. Pathol."},{"key":"552_CR58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jth.15179","volume":"19","author":"L Nicolai","year":"2020","unstructured":"Nicolai, L. et al. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J. Thromb. Haemost. 19, 574\u2013581 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR59","doi-asserted-by":"publisher","first-page":"7878","DOI":"10.4049\/jimmunol.0804049","volume":"182","author":"M Doss","year":"2009","unstructured":"Doss, M. et al. Interactions of \u03b1-, \u03b2-, and \u03b8-defensins with influenza A virus and surfactant protein D. J. Immunol. 182, 7878\u20137887 (2009).","journal-title":"J. Immunol."},{"key":"552_CR60","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.4049\/jimmunol.176.11.6962","volume":"176","author":"KL Hartshorn","year":"2006","unstructured":"Hartshorn, K. L., White, M. R., Tecle, T., Holmskov, U. & Crouch, E. C. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J. Immunol. 176, 6962\u20136972 (2006).","journal-title":"J. Immunol."},{"key":"552_CR61","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/521027","volume":"196","author":"M Salvatore","year":"2007","unstructured":"Salvatore, M. et al. \u03b1-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J. Infect. Dis. 196, 835\u2013843 (2007).","journal-title":"J. Infect. Dis."},{"key":"552_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025333","volume":"6","author":"PG Barlow","year":"2011","unstructured":"Barlow, P. G. et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS ONE 6, e25333 (2011).","journal-title":"PLoS ONE"},{"key":"552_CR63","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(97)11084-4","volume":"351","author":"CR Meier","year":"1998","unstructured":"Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C. & Jick, H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 351, 1467\u20131471 (1998).","journal-title":"Lancet"},{"key":"552_CR64","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa041747","volume":"351","author":"L Smeeth","year":"2004","unstructured":"Smeeth, L. et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 351, 2611\u20132618 (2004).","journal-title":"N. Engl. J. Med."},{"key":"552_CR65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.111.040766","volume":"125","author":"VF Corrales-Medina","year":"2012","unstructured":"Corrales-Medina, V. F. et al. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125, 773\u2013781 (2012).","journal-title":"Circulation"},{"key":"552_CR66","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.113.006699","volume":"129","author":"M Dalager-Pedersen","year":"2014","unstructured":"Dalager-Pedersen, M., Sogaard, M., Schonheyder, H. C., Nielsen, H. & Thomsen, R. W. Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation 129, 1387\u20131396 (2014).","journal-title":"Circulation"},{"key":"552_CR67","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3389\/fimmu.2019.02569","volume":"10","author":"N Beristain-Covarrubias","year":"2019","unstructured":"Beristain-Covarrubias, N. et al. Understanding infection-induced thrombosis: lessons learned from animal models. Front. Immunol. 10, 2569 (2019).","journal-title":"Front. Immunol."},{"key":"552_CR68","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa043526","volume":"352","author":"JT Grayston","year":"2005","unstructured":"Grayston, J. T. et al. Azithromycin for the secondary prevention of coronary events. N. Engl. J. Med. 352, 1637\u20131645 (2005).","journal-title":"N. Engl. J. Med."},{"key":"552_CR69","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1001\/jama.290.11.1459","volume":"290","author":"CM O\u2019Connor","year":"2003","unstructured":"O\u2019Connor, C. M. et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290, 1459\u20131466 (2003).","journal-title":"JAMA"},{"key":"552_CR70","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","volume":"129","author":"B McDonald","year":"2017","unstructured":"McDonald, B. et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood 129, 1357\u20131367 (2017).","journal-title":"Blood"},{"key":"552_CR71","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.120.046677","volume":"143","author":"A Schumski","year":"2020","unstructured":"Schumski, A. et al. Endotoxinemia accelerates atherosclerosis via electrostatic charge-mediated monocyte adhesion. Circulation 143, 254\u2013266 (2020).","journal-title":"Circulation"},{"key":"552_CR72","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/j.1538-7836.2011.04422.x","volume":"9","author":"CT Ammollo","year":"2011","unstructured":"Ammollo, C. T., Semeraro, F., Xu, J., Esmon, N. L. & Esmon, C. T. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J. Thromb. Haemost. 9, 1795\u20131803 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR73","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/jth.12677","volume":"12","author":"F Semeraro","year":"2014","unstructured":"Semeraro, F., Ammollo, C. T., Esmon, N. L. & Esmon, C. T. Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells. J. Thromb. Haemost. 12, 1697\u20131702 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR74","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2011-03-343061","volume":"118","author":"F Semeraro","year":"2011","unstructured":"Semeraro, F. et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118, 1952\u20131961 (2011).","journal-title":"Blood"},{"key":"552_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/cei.12663","volume":"182","author":"A Landsem","year":"2015","unstructured":"Landsem, A. et al. The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood. Clin. Exp. Immunol. 182, 81\u201389 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"552_CR76","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1177\/1753425913502099","volume":"20","author":"R Ovstebo","year":"2014","unstructured":"Ovstebo, R. et al. Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood. Innate Immun. 20, 552\u2013560 (2014).","journal-title":"Innate Immun."},{"key":"552_CR77","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1373\/clinchem.2015.251314","volume":"62","author":"I Norgaard","year":"2016","unstructured":"Norgaard, I., Nielsen, S. F. & Nordestgaard, B. G. Complement C3 and high risk of venous thromboembolism: 80517 individuals from the Copenhagen general population study. Clin. Chem. 62, 525\u2013534 (2016).","journal-title":"Clin. Chem."},{"key":"552_CR78","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua, G. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7, e575\u2013e582 (2020).","journal-title":"Lancet Haematol."},{"key":"552_CR79","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N. Engl. J. Med. 382, e38 (2020).","journal-title":"N. Engl. J. Med."},{"key":"552_CR80","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"552_CR81","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N., Li, D., Wang, X. & Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18, 844\u2013847 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR82","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620\u20132629 (2020).","journal-title":"J. Clin. Invest."},{"key":"552_CR83","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637 (2004).","journal-title":"J. Pathol."},{"key":"552_CR84","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418 (2020).","journal-title":"Lancet"},{"key":"552_CR85","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jth.15191","volume":"19","author":"I Mancini","year":"2020","unstructured":"Mancini, I. et al. The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J. Thromb. Haemost. 19, 513\u2013521 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR86","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cell.2020.10.005","volume":"183","author":"M Aid","year":"2020","unstructured":"Aid, M. et al. Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell 183, 1354\u20131366 (2020).","journal-title":"Cell"},{"key":"552_CR87","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11739-020-02394-0","volume":"15","author":"M Bazzan","year":"2020","unstructured":"Bazzan, M. et al. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients. Intern. Emerg. Med. 15, 861\u2013863 (2020).","journal-title":"Intern. Emerg. Med."},{"key":"552_CR88","doi-asserted-by":"publisher","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","volume":"12","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl Med. 12, eabd3876 (2020).","journal-title":"Sci. Transl Med."},{"key":"552_CR89","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1182\/blood.2020007214","volume":"136","author":"BK Manne","year":"2020","unstructured":"Manne, B. K. et al. Platelet gene expression and function in COVID-19 patients. Blood 136, 1317\u20131329 (2020).","journal-title":"Blood"},{"key":"552_CR90","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10921","volume":"484","author":"AR Everitt","year":"2012","unstructured":"Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519\u2013523 (2012).","journal-title":"Nature"},{"key":"552_CR91","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","volume":"222","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J. Infect. Dis. 222, 34\u201337 (2020).","journal-title":"J. Infect. Dis."},{"key":"552_CR92","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.immuni.2020.11.017","volume":"53","author":"JP Bernardes","year":"2020","unstructured":"Bernardes, J. P. et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity 53, 1296\u20131314 (2020).","journal-title":"Immunity"},{"key":"552_CR93","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2018-09-873984","volume":"133","author":"RA Campbell","year":"2019","unstructured":"Campbell, R. A. et al. Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. Blood 133, 2013\u20132026 (2019).","journal-title":"Blood"},{"key":"552_CR94","volume":"5","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight 5, e138999 (2020).","journal-title":"JCI Insight"},{"key":"552_CR95","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton, E. A. et al. Neutrophil extracellular traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169\u20131179 (2020).","journal-title":"Blood"},{"key":"552_CR96","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1182\/blood-2013-07-516484","volume":"123","author":"J Rossaint","year":"2014","unstructured":"Rossaint, J. et al. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation. Blood 123, 2573\u20132584 (2014).","journal-title":"Blood"},{"key":"552_CR97","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1172\/JCI83873","volume":"126","author":"CC Yost","year":"2016","unstructured":"Yost, C. C. et al. Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation. J. Clin. Invest. 126, 3783\u20133798 (2016).","journal-title":"J. Clin. Invest."},{"key":"552_CR98","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","volume":"217","author":"FP Veras","year":"2020","unstructured":"Veras, F. P. et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 217, e20201129 (2020).","journal-title":"J. Exp. Med."},{"key":"552_CR99","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jamacardio.2020.7308","volume":"6","author":"A Blasco","year":"2021","unstructured":"Blasco, A. et al. Assessment of neutrophil extracellular traps in coronary thrombus of a case series of patients with COVID-19 and myocardial infarction. JAMA Cardiol. 6, 469\u2013474 (2021).","journal-title":"JAMA Cardiol."},{"key":"552_CR100","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood.2020007252","volume":"136","author":"ED Hottz","year":"2020","unstructured":"Hottz, E. D. et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood 136, 1330\u20131341 (2020).","journal-title":"Blood"},{"key":"552_CR101","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","volume":"26","author":"V Ramlall","year":"2020","unstructured":"Ramlall, V. et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat. Med. 26, 1609\u20131615 (2020).","journal-title":"Nat. Med."},{"key":"552_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro, C. et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 220, 1\u201313 (2020).","journal-title":"Transl Res."},{"key":"552_CR103","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros, P. et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Invest. 130, 6151\u20136157 (2020).","journal-title":"J. Clin. Invest."},{"key":"552_CR104","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01753-18","volume":"9","author":"LE Gralinski","year":"2018","unstructured":"Gralinski, L. E. et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9, e01753-18 (2018).","journal-title":"mBio"},{"key":"552_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0063-8","volume":"7","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg. Microbes Infect. 7, 77 (2018).","journal-title":"Emerg. Microbes Infect."},{"key":"552_CR106","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1164\/rccm.201406-1031OC","volume":"191","author":"VB Le","year":"2015","unstructured":"Le, V. B. et al. Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am. J. Respir. Crit. Care Med. 191, 804\u2013819 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"552_CR107","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","volume":"20","author":"AM Risitano","year":"2020","unstructured":"Risitano, A. M. et al. Complement as a target in COVID-19? Nat. Rev. Immunol. 20, 343\u2013344 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"552_CR108","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1182\/blood-2012-06-437392","volume":"121","author":"D Duerschmied","year":"2013","unstructured":"Duerschmied, D. et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood 121, 1008\u20131015 (2013).","journal-title":"Blood"},{"key":"552_CR109","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1160\/TH13-04-0341","volume":"110","author":"E Karshovska","year":"2013","unstructured":"Karshovska, E., Weber, C. & von Hundelshausen, P. Platelet chemokines in health and disease. Thromb. Haemost. 110, 894\u2013902 (2013).","journal-title":"Thromb. Haemost."},{"key":"552_CR110","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/359848a0","volume":"359","author":"T Palabrica","year":"1992","unstructured":"Palabrica, T. et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359, 848\u2013851 (1992).","journal-title":"Nature"},{"key":"552_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15559","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIb\u03b1. Nat. Commun. 8, 15559 (2017).","journal-title":"Nat. Commun."},{"key":"552_CR112","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0741-5214(97)70211-8","volume":"25","author":"LJ Downing","year":"1997","unstructured":"Downing, L. J. et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J. Vasc. Surg. 25, 816\u2013827 (1997).","journal-title":"J. Vasc. Surg."},{"key":"552_CR113","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jvs.2005.04.045","volume":"42","author":"DD Myers Jr.","year":"2005","unstructured":"Myers, D. D. Jr. et al. Decreased venous thrombosis with an oral inhibitor of P selectin. J. Vasc. Surg. 42, 329\u2013336 (2005).","journal-title":"J. Vasc. Surg."},{"key":"552_CR114","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","volume":"24","author":"AD Blann","year":"2003","unstructured":"Blann, A. D., Nadar, S. K. & Lip, G. Y. The adhesion molecule P-selectin and cardiovascular disease. Eur. Heart J. 24, 2166\u20132179 (2003).","journal-title":"Eur. Heart J."},{"key":"552_CR115","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/01.CIR.103.4.491","volume":"103","author":"PM Ridker","year":"2001","unstructured":"Ridker, P. M., Buring, J. E. & Rifai, N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 103, 491\u2013495 (2001).","journal-title":"Circulation"},{"key":"552_CR116","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehv419","volume":"37","author":"J Riegger","year":"2016","unstructured":"Riegger, J. et al. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium. Eur. Heart J. 37, 1538\u20131549 (2016).","journal-title":"Eur. Heart J."},{"key":"552_CR117","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/jth.12571","volume":"12","author":"AS Savchenko","year":"2014","unstructured":"Savchenko, A. S. et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J. Thromb. Haemost. 12, 860\u2013870 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR118","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1182\/blood-2015-01-624023","volume":"126","author":"J Etulain","year":"2015","unstructured":"Etulain, J. et al. P-selectin promotes neutrophil extracellular trap formation in mice. Blood 126, 242\u2013246 (2015).","journal-title":"Blood"},{"key":"552_CR119","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1111\/jth.12710","volume":"12","author":"N Maugeri","year":"2014","unstructured":"Maugeri, N. et al. Activated platelets present high mobility group Box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J. Thromb. Haemost. 12, 2074\u20132088 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR120","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1182\/blood-2016-04-710632","volume":"128","author":"K Stark","year":"2016","unstructured":"Stark, K. et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435\u20132449 (2016).","journal-title":"Blood"},{"key":"552_CR121","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2018-10-862243","volume":"133","author":"DF Noubouossie","year":"2019","unstructured":"Noubouossie, D. F., Reeves, B. N., Strahl, B. D. & Key, N. S. Neutrophils: back in the thrombosis spotlight. Blood 133, 2186\u20132197 (2019).","journal-title":"Blood"},{"key":"552_CR122","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2016-06-722298","volume":"129","author":"DF Noubouossie","year":"2017","unstructured":"Noubouossie, D. F. et al. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood 129, 1021\u20131029 (2017).","journal-title":"Blood"},{"key":"552_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03925-2","volume":"9","author":"J Pircher","year":"2018","unstructured":"Pircher, J. et al. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation. Nat. Commun. 9, 1523 (2018).","journal-title":"Nat. Commun."},{"key":"552_CR124","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1161\/CIRCRESAHA.112.265868","volume":"110","author":"Y Doring","year":"2012","unstructured":"Doring, Y. et al. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ. Res. 110, 1052\u20131056 (2012).","journal-title":"Circ. Res."},{"key":"552_CR125","doi-asserted-by":"publisher","first-page":"103ra198","DOI":"10.1126\/scitranslmed.3002531","volume":"3","author":"O Soehnlein","year":"2011","unstructured":"Soehnlein, O. et al. Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci. Transl Med. 3, 103ra198 (2011).","journal-title":"Sci. Transl Med."},{"key":"552_CR126","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019000518","volume":"134","author":"C Marx","year":"2019","unstructured":"Marx, C. et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood 134, 1859\u20131872 (2019).","journal-title":"Blood"},{"key":"552_CR127","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood-2006-02-004945","volume":"109","author":"C Moosbauer","year":"2007","unstructured":"Moosbauer, C. et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109, 995\u20131002 (2007).","journal-title":"Blood"},{"key":"552_CR128","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1084\/jem.20161070","volume":"214","author":"S Uderhardt","year":"2017","unstructured":"Uderhardt, S. et al. Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease. J. Exp. Med. 214, 2121\u20132138 (2017).","journal-title":"J. Exp. Med."},{"key":"552_CR129","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/1076029609348647","volume":"16","author":"PR Ames","year":"2010","unstructured":"Ames, P. R., Margaglione, M., Mackie, S. & Alves, J. D. Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview. Clin. Appl. Thromb. Hemost. 16, 628\u2013636 (2010).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"552_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111862","volume":"9","author":"M Cugno","year":"2014","unstructured":"Cugno, M., Marzano, A. V., Lorini, M., Carbonelli, V. & Tedeschi, A. Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLoS ONE 9, e111862 (2014).","journal-title":"PLoS ONE"},{"key":"552_CR131","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004658","volume":"95","author":"SJ Gao","year":"2016","unstructured":"Gao, S. J. et al. Hypereosinophilic syndrome presenting with multiple organ infiltration and deep venous thrombosis: a case report and literature review. Medicine 95, e4658 (2016).","journal-title":"Medicine"},{"key":"552_CR132","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nm.1855","volume":"14","author":"S Yousefi","year":"2008","unstructured":"Yousefi, S. et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 14, 949\u2013953 (2008).","journal-title":"Nat. Med."},{"key":"552_CR133","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinte.160.6.761","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit, J. A. et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch. Intern. Med. 160, 761\u2013768 (2000).","journal-title":"Arch. Intern. Med."},{"key":"552_CR134","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3324\/haematol.10516","volume":"92","author":"P Prandoni","year":"2007","unstructured":"Prandoni, P. et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 92, 199\u2013205 (2007).","journal-title":"Haematologica"},{"key":"552_CR135","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","volume":"379","author":"SZ Goldhaber","year":"2012","unstructured":"Goldhaber, S. Z. & Bounameaux, H. Pulmonary embolism and deep vein thrombosis. Lancet 379, 1835\u20131846 (2012).","journal-title":"Lancet"},{"key":"552_CR136","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1538-7836.2010.03852.x","volume":"8","author":"JA Nieto","year":"2010","unstructured":"Nieto, J. A. et al. Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry. J. Thromb. Haemost. 8, 1216\u20131222 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR137","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","volume":"12","author":"JA Heit","year":"2015","unstructured":"Heit, J. A. Epidemiology of venous thromboembolism. Nat. Rev. Cardiol. 12, 464\u2013474 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"552_CR138","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1055\/s-0037-1616243","volume":"86","author":"JA Heit","year":"2001","unstructured":"Heit, J. A. et al. The epidemiology of venous thromboembolism in the community. Thromb. Haemost. 86, 452\u2013463 (2001).","journal-title":"Thromb. Haemost."},{"key":"552_CR139","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1160\/TH07-03-0212","volume":"98","author":"AT Cohen","year":"2007","unstructured":"Cohen, A. T. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb. Haemost. 98, 756\u2013764 (2007).","journal-title":"Thromb. Haemost."},{"key":"552_CR140","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00047.2009","volume":"91","author":"JJ Chiu","year":"2011","unstructured":"Chiu, J. J. & Chien, S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 91, 327\u2013387 (2011).","journal-title":"Physiol. Rev."},{"key":"552_CR141","doi-asserted-by":"publisher","first-page":"C1100","DOI":"10.1152\/ajpcell.1999.276.5.C1100","volume":"276","author":"S Mohan","year":"1999","unstructured":"Mohan, S., Mohan, N., Valente, A. J. & Sprague, E. A. Regulation of low shear flow-induced HAEC VCAM-1 expression and monocyte adhesion. Am. J. Physiol. 276, C1100\u2013C1107 (1999).","journal-title":"Am. J. Physiol."},{"key":"552_CR142","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1073\/pnas.1620458114","volume":"114","author":"N Gupta","year":"2017","unstructured":"Gupta, N. et al. Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc. Natl Acad. Sci. USA 114, 4763\u20134768 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"552_CR143","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1161\/CIRCRESAHA.117.311185","volume":"121","author":"T Ponomaryov","year":"2017","unstructured":"Ponomaryov, T., Payne, H., Fabritz, L., Wagner, D. D. & Brill, A. Mast cells granular contents are crucial for deep vein thrombosis in mice. Circ. Res. 121, 941\u2013950 (2017).","journal-title":"Circ. Res."},{"key":"552_CR144","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1182\/blood-2016-11-749879","volume":"129","author":"S Subramaniam","year":"2017","unstructured":"Subramaniam, S. et al. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129, 2291\u20132302 (2017).","journal-title":"Blood"},{"key":"552_CR145","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1182\/blood-2018-05-850859","volume":"132","author":"T Yago","year":"2018","unstructured":"Yago, T., Liu, Z., Ahamed, J. & McEver, R. P. Cooperative PSGL-1 and CXCR2 signaling in neutrophils promotes deep vein thrombosis in mice. Blood 132, 1426\u20131437 (2018).","journal-title":"Blood"},{"key":"552_CR146","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","volume":"10","author":"A Brill","year":"2012","unstructured":"Brill, A. et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J. Thromb. Haemost. 10, 136\u2013144 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR147","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molimm.2012.10.037","volume":"55","author":"E Venereau","year":"2013","unstructured":"Venereau, E., Schiraldi, M., Uguccioni, M. & Bianchi, M. E. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol. Immunol. 55, 76\u201382 (2013).","journal-title":"Mol. Immunol."},{"key":"552_CR148","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/aje\/kws130","volume":"176","author":"LS Magder","year":"2012","unstructured":"Magder, L. S. & Petri, M. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am. J. Epidemiol. 176, 708\u2013719 (2012).","journal-title":"Am. J. Epidemiol."},{"key":"552_CR149","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","volume":"188","author":"J Leffler","year":"2012","unstructured":"Leffler, J. et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol. 188, 3522\u20133531 (2012).","journal-title":"J. Immunol."},{"key":"552_CR150","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1177\/0961203312457210","volume":"21","author":"C Lood","year":"2012","unstructured":"Lood, C. et al. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus\u2013a possible link to venous thrombosis? Lupus 21, 1423\u20131432 (2012).","journal-title":"Lupus"},{"key":"552_CR151","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrrheum.2010.47","volume":"6","author":"G Espinosa","year":"2010","unstructured":"Espinosa, G. & Cervera, R. Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat. Rev. Rheumatol. 6, 296\u2013300 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"552_CR152","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","volume":"106","author":"F Fischetti","year":"2005","unstructured":"Fischetti, F. et al. Thrombus formation induced by antibodies to \u03b22-glycoprotein I is complement dependent and requires a priming factor. Blood 106, 2340\u20132346 (2005).","journal-title":"Blood"},{"key":"552_CR153","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI200318817","volume":"112","author":"G Girardi","year":"2003","unstructured":"Girardi, G. et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 112, 1644\u20131654 (2003).","journal-title":"J. Clin. Invest."},{"key":"552_CR154","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nm1121","volume":"10","author":"G Girardi","year":"2004","unstructured":"Girardi, G., Redecha, P. & Salmon, J. E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 10, 1222\u20131226 (2004).","journal-title":"Nat. Med."},{"key":"552_CR155","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo, G. S. et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl Med. 3, 73ra20 (2011).","journal-title":"Sci. Transl Med."},{"key":"552_CR156","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon, D. H. et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107, 1303\u20131307 (2003).","journal-title":"Circulation"},{"key":"552_CR157","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/ar2323","volume":"9","author":"S Hannawi","year":"2007","unstructured":"Hannawi, S., Haluska, B., Marwick, T. H. & Thomas, R. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res. Ther. 9, R116 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"552_CR158","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/art.20853","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers, H. et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 52, 402\u2013411 (2005).","journal-title":"Arthritis Rheum."},{"key":"552_CR159","doi-asserted-by":"publisher","first-page":"178ra140","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur, R. et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl Med. 5, 178ra140 (2013).","journal-title":"Sci. Transl Med."},{"key":"552_CR160","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1084\/jem.20012044","volume":"196","author":"S Massberg","year":"2002","unstructured":"Massberg, S. et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196, 887\u2013896 (2002).","journal-title":"J. Exp. Med."},{"key":"552_CR161","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1161\/CIRCULATIONAHA.105.539221","volume":"112","author":"S Massberg","year":"2005","unstructured":"Massberg, S. et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112, 1180\u20131188 (2005).","journal-title":"Circulation"},{"key":"552_CR162","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/ATVBAHA.115.307074","volume":"36","author":"N Gerdes","year":"2016","unstructured":"Gerdes, N. et al. Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes. Arterioscler. Thromb. Vasc. Biol. 36, 482\u2013490 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"552_CR163","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.110.961714","volume":"122","author":"M Drechsler","year":"2010","unstructured":"Drechsler, M., Megens, R. T., van Zandvoort, M., Weber, C. & Soehnlein, O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122, 1837\u20131845 (2010).","journal-title":"Circulation"},{"key":"552_CR164","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nm.1898","volume":"15","author":"RR Koenen","year":"2009","unstructured":"Koenen, R. R. et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15, 97\u2013103 (2009).","journal-title":"Nat. Med."},{"key":"552_CR165","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1084\/jem.20051772","volume":"203","author":"S Massberg","year":"2006","unstructured":"Massberg, S. et al. Platelets secrete stromal cell-derived factor 1\u03b1 and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203, 1221\u20131233 (2006).","journal-title":"J. Exp. Med."},{"key":"552_CR166","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41586-019-1167-6","volume":"569","author":"C Silvestre-Roig","year":"2019","unstructured":"Silvestre-Roig, C. et al. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death. Nature 569, 236\u2013240 (2019).","journal-title":"Nature"},{"key":"552_CR167","doi-asserted-by":"publisher","first-page":"4980251","DOI":"10.1155\/2016\/4980251","volume":"2016","author":"GL Xia","year":"2016","unstructured":"Xia, G. L., Wang, Y. K. & Huang, Z. Q. The correlation of serum myeloid-related protein-8\/14 and eosinophil cationic protein in patients with coronary artery disease. BioMed. Res. Int. 2016, 4980251 (2016).","journal-title":"BioMed. Res. Int."},{"key":"552_CR168","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2010.02.038","volume":"211","author":"G Niccoli","year":"2010","unstructured":"Niccoli, G. et al. Eosinophil cationic protein: a new biomarker of coronary atherosclerosis. Atherosclerosis 211, 606\u2013611 (2010).","journal-title":"Atherosclerosis"},{"key":"552_CR169","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1161\/01.CIR.102.18.2185","volume":"102","author":"KJ Haley","year":"2000","unstructured":"Haley, K. J. et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102, 2185\u20132189 (2000).","journal-title":"Circulation"},{"key":"552_CR170","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/path.5212","volume":"247","author":"KR Pertiwi","year":"2018","unstructured":"Pertiwi, K. R. et al. Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time-dependent manner during atherothrombosis. J. Pathol. 247, 505\u2013512 (2018).","journal-title":"J. Pathol."},{"key":"552_CR171","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002860","volume":"5","author":"RA van Dijk","year":"2016","unstructured":"van Dijk, R. A. et al. Systematic evaluation of the cellular innate immune response during the process of human atherosclerosis. J. Am. Heart Assoc. 5, e002860 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"552_CR172","doi-asserted-by":"publisher","first-page":"e2346","DOI":"10.1212\/WNL.0000000000009532","volume":"94","author":"J Novotny","year":"2020","unstructured":"Novotny, J. et al. Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction. Neurology 94, e2346\u2013e2360 (2020).","journal-title":"Neurology"},{"key":"552_CR173","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/ng.323","volume":"41","author":"DF Gudbjartsson","year":"2009","unstructured":"Gudbjartsson, D. F. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41, 342\u2013347 (2009).","journal-title":"Nat. Genet."},{"key":"552_CR174","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1055\/s-0039-1692983","volume":"119","author":"J Pircher","year":"2019","unstructured":"Pircher, J., Engelmann, B., Massberg, S. & Schulz, C. Platelet-neutrophil crosstalk in atherothrombosis. Thromb. Haemost. 119, 1274\u20131282 (2019).","journal-title":"Thromb. Haemost."},{"key":"552_CR175","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.jacc.2013.03.003","volume":"61","author":"JC Tardif","year":"2013","unstructured":"Tardif, J. C. et al. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J. Am. Coll. Cardiol. 61, 2048\u20132055 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"552_CR176","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1182\/blood.2019002846","volume":"135","author":"N Dhanesha","year":"2020","unstructured":"Dhanesha, N. et al. Targeting myeloid-cell specific integrin \u03b19\u03b21 inhibits arterial thrombosis in mice. Blood 135, 857\u2013861 (2020).","journal-title":"Blood"},{"key":"552_CR177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071447","volume":"8","author":"N Faraday","year":"2013","unstructured":"Faraday, N. et al. Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils. PLoS ONE 8, e71447 (2013).","journal-title":"PLoS ONE"},{"key":"552_CR178","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.116.024790","volume":"134","author":"A Ortega-Gomez","year":"2016","unstructured":"Ortega-Gomez, A. et al. Cathepsin G controls arterial but not venular myeloid cell recruitment. Circulation 134, 1176\u20131188 (2016).","journal-title":"Circulation"},{"key":"552_CR179","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1172\/JCI81660","volume":"125","author":"S Vogel","year":"2015","unstructured":"Vogel, S. et al. Platelet-derived HMGB1 is a critical mediator of thrombosis. J. Clin. Invest. 125, 4638\u20134654 (2015).","journal-title":"J. Clin. Invest."},{"key":"552_CR180","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCRESAHA.117.312494","volume":"123","author":"G Franck","year":"2018","unstructured":"Franck, G. et al. Roles of PAD4 and NETosis in experimental atherosclerosis and arterial injury: implications for superficial erosion. Circ. Res. 123, 33\u201342 (2018).","journal-title":"Circ. Res."},{"key":"552_CR181","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3389\/fimmu.2018.01680","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Myeloid-specific deletion of peptidylarginine deiminase 4 mitigates atherosclerosis. Front. Immunol. 9, 1680 (2018).","journal-title":"Front. Immunol."},{"key":"552_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190728","volume":"13","author":"J Novotny","year":"2018","unstructured":"Novotny, J. et al. Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation. PLoS ONE 13, e0190728 (2018).","journal-title":"PLoS ONE"},{"key":"552_CR183","doi-asserted-by":"publisher","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","volume":"114","author":"A Schreiber","year":"2017","unstructured":"Schreiber, A. et al. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc. Natl Acad. Sci. USA 114, E9618\u2013E9625 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"552_CR184","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cei.12654","volume":"181","author":"H Wang","year":"2015","unstructured":"Wang, H., Wang, C., Zhao, M. H. & Chen, M. Neutrophil extracellular traps can activate alternative complement pathways. Clin. Exp. Immunol. 181, 518\u2013527 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"552_CR185","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1538-7836.2009.03334.x","volume":"7","author":"FC Gushiken","year":"2009","unstructured":"Gushiken, F. C., Han, H., Li, J., Rumbaut, R. E. & Afshar-Kharghan, V. Abnormal platelet function in C3-deficient mice. J. Thromb. Haemost. 7, 865\u2013870 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"552_CR186","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.118.034600","volume":"138","author":"RJ Sauter","year":"2018","unstructured":"Sauter, R. J. et al. Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis. Circulation 138, 1720\u20131735 (2018).","journal-title":"Circulation"},{"key":"552_CR187","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"552_CR188","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal, S. et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377, 111\u2013121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"552_CR189","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster, J. J. et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842\u2013847 (2017).","journal-title":"Science"},{"key":"552_CR190","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James, C. et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434, 1144\u20131148 (2005).","journal-title":"Nature"},{"key":"552_CR191","doi-asserted-by":"publisher","first-page":"eaan8292","DOI":"10.1126\/scitranslmed.aan8292","volume":"10","author":"O Wolach","year":"2018","unstructured":"Wolach, O. et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci. Transl Med. 10, eaan8292 (2018).","journal-title":"Sci. Transl Med."},{"key":"552_CR192","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","volume":"123","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 (V617F) Mice. Circ. Res. 123, e35\u2013e47 (2018).","journal-title":"Circ. Res."},{"key":"552_CR193","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","volume":"55","author":"AH Cull","year":"2017","unstructured":"Cull, A. H., Snetsinger, B., Buckstein, R., Wells, R. A. & Rauh, M. J. Tet2 restrains inflammatory gene expression in macrophages. Exp. Hematol. 55, 56\u201370 (2017).","journal-title":"Exp. Hematol."},{"key":"552_CR194","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389\u2013393 (2015).","journal-title":"Nature"},{"key":"552_CR195","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3324\/haematol.2019.235994","volume":"105","author":"A Veninga","year":"2020","unstructured":"Veninga, A., De Simone, I., Heemskerk, J. W. M., Cate, H. T. & van der Meijden, P. E. J. Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding. Haematologica 105, 2020\u20132031 (2020).","journal-title":"Haematologica"},{"key":"552_CR196","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca, M. P. et al. Rivaroxaban in peripheral artery disease after revascularization. N. Engl. J. Med. 382, 1994\u20132004 (2020).","journal-title":"N. Engl. J. Med."},{"key":"552_CR197","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMra1011670","volume":"364","author":"JI Borissoff","year":"2011","unstructured":"Borissoff, J. I., Spronk, H. M. & ten Cate, H. The hemostatic system as a modulator of atherosclerosis. N. Engl. J. Med. 364, 1746\u20131760 (2011).","journal-title":"N. Engl. J. Med."},{"key":"552_CR198","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","volume":"377","author":"JW Eikelboom","year":"2017","unstructured":"Eikelboom, J. W. et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N. Engl. J. Med. 377, 1319\u20131330 (2017).","journal-title":"N. Engl. J. Med."},{"key":"552_CR199","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/CIRCRESAHA.120.317219","volume":"128","author":"I Gadi","year":"2020","unstructured":"Gadi, I. et al. Different DOACs control inflammation in cardiac ischemia-reperfusion differently. Circ. Res. 128, 513\u2013529 (2020).","journal-title":"Circ. Res."},{"key":"552_CR200","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2015.03.023","volume":"242","author":"T Hara","year":"2015","unstructured":"Hara, T. et al. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis 242, 639\u2013646 (2015).","journal-title":"Atherosclerosis"},{"key":"552_CR201","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","volume":"64","author":"TK Vu","year":"1991","unstructured":"Vu, T. K., Hung, D. T., Wheaton, V. I. & Coughlin, S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057\u20131068 (1991).","journal-title":"Cell"},{"key":"552_CR202","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf, S. M. et al. Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 383, 1838\u20131847 (2020).","journal-title":"N. Engl. J. Med."},{"key":"552_CR203","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"552_CR204","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif, J. C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381, 2497\u20132505 (2019).","journal-title":"N. Engl. J. Med."},{"key":"552_CR205","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1055\/s-0040-1701206","volume":"4","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof, P. et al. Effects of rivaroxaban on biomarkers of coagulation and inflammation: a post hoc analysis of the X-VeRT TRIAL. TH Open 4, e20\u2013e32 (2020).","journal-title":"TH Open"},{"key":"552_CR206","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.ATV.0000151279.35780.2d","volume":"25","author":"G Busch","year":"2005","unstructured":"Busch, G. et al. Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25, 461\u2013466 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"552_CR207","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbamcr.2006.04.010","volume":"1763","author":"V Daubie","year":"2006","unstructured":"Daubie, V. et al. Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation. Biochim. Biophys. Acta 1763, 860\u2013869 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"552_CR208","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.4049\/jimmunol.161.8.4318","volume":"161","author":"NH Senden","year":"1998","unstructured":"Senden, N. H. et al. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J. Immunol. 161, 4318\u20134324 (1998).","journal-title":"J. Immunol."},{"key":"552_CR209","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012195","volume":"8","author":"H Ichikawa","year":"2019","unstructured":"Ichikawa, H. et al. Rivaroxaban, a direct factor Xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway. J. Am. Heart Assoc. 8, e012195 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"552_CR210","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1182\/blood-2013-07-514984","volume":"123","author":"KC Wildhagen","year":"2014","unstructured":"Wildhagen, K. C. et al. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood 123, 1098\u20131101 (2014).","journal-title":"Blood"},{"key":"552_CR211","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/ijms21041391","volume":"21","author":"A Mansour","year":"2020","unstructured":"Mansour, A., Bachelot-Loza, C., Nesseler, N., Gaussem, P. & Gouin-Thibault, I. P2Y12 inhibition beyond thrombosis: effects on inflammation. Int. J. Mol. Sci. 21, 1391 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"552_CR212","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","volume":"19","author":"N Mackman","year":"2020","unstructured":"Mackman, N., Bergmeier, W., Stouffer, G. A. & Weitz, J. I. Therapeutic strategies for thrombosis: new targets and approaches. Nat. Rev. Drug Discov. 19, 333\u2013352 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"552_CR213","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jcin.2017.05.064","volume":"10","author":"HS Jeong","year":"2017","unstructured":"Jeong, H. S. et al. Comparison of ticagrelor versus prasugrel for inflammation, vascular function, and circulating endothelial progenitor cells in diabetic patients with non-ST-segment elevation acute coronary syndrome requiring coronary stenting: a prospective, randomized, crossover trial. JACC Cardiovasc. Interv. 10, 1646\u20131658 (2017).","journal-title":"JACC Cardiovasc. Interv."},{"key":"552_CR214","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","volume":"183","author":"T Morris","year":"2009","unstructured":"Morris, T. et al. Effects of low-dose aspirin on acute inflammatory responses in humans. J. Immunol. 183, 2089\u20132096 (2009).","journal-title":"J. Immunol."},{"key":"552_CR215","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1084\/jem.20040566","volume":"200","author":"MJ Paul-Clark","year":"2004","unstructured":"Paul-Clark, M. J., Van Cao, T., Moradi-Bidhendi, N., Cooper, D. & Gilroy, D. W. 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J. Exp. Med. 200, 69\u201378 (2004).","journal-title":"J. Exp. Med."},{"key":"552_CR216","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature11260","volume":"487","author":"P Dutta","year":"2012","unstructured":"Dutta, P. et al. Myocardial infarction accelerates atherosclerosis. Nature 487, 325\u2013329 (2012).","journal-title":"Nature"},{"key":"552_CR217","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.115.016160","volume":"132","author":"HB Sager","year":"2015","unstructured":"Sager, H. B. et al. Targeting interleukin-1\u03b2 reduces leukocyte production after acute myocardial infarction. Circulation 132, 1880\u20131890 (2015).","journal-title":"Circulation"},{"key":"552_CR218","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41591-018-0124-5","volume":"24","author":"D Gomez","year":"2018","unstructured":"Gomez, D. et al. Interleukin-1\u03b2 has atheroprotective effects in advanced atherosclerotic lesions of mice. Nat. Med. 24, 1418\u20131429 (2018).","journal-title":"Nat. Med."},{"key":"552_CR219","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1172\/JCI43713","volume":"122","author":"MR Alexander","year":"2012","unstructured":"Alexander, M. R. et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J. Clin. Invest. 122, 70\u201379 (2012).","journal-title":"J. Clin. Invest."},{"key":"552_CR220","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker, P. M. et al. Low-dose methotrexate for the prevention of atherosclerotic events. N. Engl. J. Med. 380, 752\u2013762 (2019).","journal-title":"N. Engl. J. Med."},{"key":"552_CR221","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2019.07.002","volume":"51","author":"LE Munoz","year":"2019","unstructured":"Munoz, L. E. et al. Neutrophil extracellular traps initiate gallstone formation. Immunity 51, 443\u2013450 (2019).","journal-title":"Immunity"},{"key":"552_CR222","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"552_CR223","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","volume":"142","author":"TSJ Opstal","year":"2020","unstructured":"Opstal, T. S. J. et al. Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease: a LoDoCo2 proteomic substudy. Circulation 142, 1996\u20131998 (2020).","journal-title":"Circulation"},{"key":"552_CR224","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","volume":"3","author":"M Castro","year":"2015","unstructured":"Castro, M. et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir. Med. 3, 355\u2013366 (2015).","journal-title":"Lancet Respir. Med."},{"key":"552_CR225","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","volume":"388","author":"JM FitzGerald","year":"2016","unstructured":"FitzGerald, J. M. et al. Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 388, 2128\u20132141 (2016).","journal-title":"Lancet"},{"key":"552_CR226","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega, H. G. et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N. Engl. J. Med. 371, 1198\u20131207 (2014).","journal-title":"N. Engl. J. Med."},{"key":"552_CR227","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","volume":"18","author":"DC Mastellos","year":"2019","unstructured":"Mastellos, D. C., Ricklin, D. & Lambris, J. D. Clinical promise of next-generation complement therapeutics. Nat. Rev. Drug Discov. 18, 707\u2013729 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"552_CR228","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/ATVBAHA.116.307401","volume":"36","author":"E Liverani","year":"2016","unstructured":"Liverani, E., Rico, M. C., Tsygankov, A. Y., Kilpatrick, L. E. & Kunapuli, S. P. P2Y12 receptor modulates sepsis-induced inflammation. Arterioscler. Thromb. Vasc. Biol. 36, 961\u2013971 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"552_CR229","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jacbts.2018.05.005","volume":"3","author":"TR Sexton","year":"2018","unstructured":"Sexton, T. R. et al. Ticagrelor reduces thromboinflammatory markers in patients with pneumonia. JACC Basic Transl. Sci. 3, 435\u2013449 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"552_CR230","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen, P. et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 110, 4123\u20134128 (2007).","journal-title":"Blood"},{"key":"552_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-0964-9","author":"Y Dong","year":"2020","unstructured":"Dong, Y. et al. TLR4 regulates ROS and autophagy to control neutrophil extracellular traps formation against Streptococcus pneumoniae in acute otitis media. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-020-0964-9 (2020).","journal-title":"Pediatr. Res."},{"key":"552_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11037","volume":"7","author":"S Guglietta","year":"2016","unstructured":"Guglietta, S. et al. Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis. Nat. Commun. 7, 11037 (2016).","journal-title":"Nat. Commun."},{"key":"552_CR233","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","volume":"8","author":"KD Metzler","year":"2014","unstructured":"Metzler, K. D., Goosmann, C., Lubojemska, A., Zychlinsky, A. & Papayannopoulos, V. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep. 8, 883\u2013896 (2014).","journal-title":"Cell Rep."},{"key":"552_CR234","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos, V., Metzler, K. D., Hakkim, A. & Zychlinsky, A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677\u2013691 (2010).","journal-title":"J. Cell Biol."},{"key":"552_CR235","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1160\/TH15-04-0336","volume":"115","author":"TT Vu","year":"2016","unstructured":"Vu, T. T. et al. Histidine-rich glycoprotein binds DNA and RNA and attenuates their capacity to activate the intrinsic coagulation pathway. Thromb. Haemost. 115, 89\u201398 (2016).","journal-title":"Thromb. Haemost."},{"key":"552_CR236","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00230-2","volume":"8","author":"H Fu","year":"2017","unstructured":"Fu, H. et al. Flow-induced elongation of von willebrand factor precedes tension-dependent activation. Nat. Commun. 8, 324 (2017).","journal-title":"Nat. Commun."},{"key":"552_CR237","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jmb.2019.02.014","volume":"431","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y., Fu, H., Springer, T. A. & Wong, W. P. Electrostatic steering enables flow-activated von willebrand factor to bind platelet glycoprotein, revealed by single-molecule stretching and imaging. J. Mol. Biol. 431, 1380\u20131396 (2019).","journal-title":"J. Mol. Biol."},{"key":"552_CR238","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.4049\/jimmunol.146.12.4234","volume":"146","author":"A Chonn","year":"1991","unstructured":"Chonn, A., Cullis, P. R. & Devine, D. V. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146, 4234\u20134241 (1991).","journal-title":"J. Immunol."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00552-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:13:54Z","timestamp":1733940834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00552-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":238,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1038\/s41569-021-00552-1","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"6 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}